EMEREN GROUP LTD (SOL) Stock Fundamental Analysis

NYSE:SOL • US75971T3014

1.94 USD
+0.01 (+0.52%)
At close: Dec 12, 2025
1.94 USD
0 (0%)
After Hours: 12/12/2025, 8:04:00 PM
Fundamental Rating

4

SOL gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 55 industry peers in the Construction & Engineering industry. While SOL seems to be doing ok healthwise, there are quite some concerns on its profitability. SOL is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year SOL has reported negative net income.
  • SOL had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: SOL reported negative net income in multiple years.
  • In the past 5 years SOL always reported negative operating cash flow.
SOL Yearly Net Income VS EBIT VS OCF VS FCFSOL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • With a Return On Assets value of -2.03%, SOL is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
  • SOL has a worse Return On Equity (-2.94%) than 70.91% of its industry peers.
Industry RankSector Rank
ROA -2.03%
ROE -2.94%
ROIC N/A
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
SOL Yearly ROA, ROE, ROICSOL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • Looking at the Gross Margin, with a value of 33.95%, SOL belongs to the top of the industry, outperforming 85.45% of the companies in the same industry.
  • In the last couple of years the Gross Margin of SOL has declined.
  • SOL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
SOL Yearly Profit, Operating, Gross MarginsSOL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

6

2. Health

2.1 Basic Checks

  • SOL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SOL has been reduced compared to 1 year ago.
  • Compared to 5 years ago, SOL has more shares outstanding
  • Compared to 1 year ago, SOL has a worse debt to assets ratio.
SOL Yearly Shares OutstandingSOL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SOL Yearly Total Debt VS Total AssetsSOL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of -0.51, we must say that SOL is in the distress zone and has some risk of bankruptcy.
  • SOL has a worse Altman-Z score (-0.51) than 89.09% of its industry peers.
  • SOL has a debt to FCF ratio of 2.04. This is a good value and a sign of high solvency as SOL would need 2.04 years to pay back of all of its debts.
  • SOL's Debt to FCF ratio of 2.04 is fine compared to the rest of the industry. SOL outperforms 76.36% of its industry peers.
  • SOL has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.20, SOL is doing good in the industry, outperforming 76.36% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.04
Altman-Z -0.51
ROIC/WACCN/A
WACC9.96%
SOL Yearly LT Debt VS Equity VS FCFSOL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • SOL has a Current Ratio of 4.28. This indicates that SOL is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.28, SOL belongs to the top of the industry, outperforming 98.18% of the companies in the same industry.
  • A Quick Ratio of 4.28 indicates that SOL has no problem at all paying its short term obligations.
  • SOL's Quick ratio of 4.28 is amongst the best of the industry. SOL outperforms 98.18% of its industry peers.
Industry RankSector Rank
Current Ratio 4.28
Quick Ratio 4.28
SOL Yearly Current Assets VS Current LiabilitesSOL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

  • The earnings per share for SOL have decreased strongly by -16.67% in the last year.
  • The Revenue for SOL has decreased by -30.50% in the past year. This is quite bad
  • Measured over the past years, SOL shows a decrease in Revenue. The Revenue has been decreasing by -5.02% on average per year.
EPS 1Y (TTM)-16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.15%
Revenue 1Y (TTM)-30.5%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%21.63%

3.2 Future

  • SOL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.80% yearly.
  • The Revenue is expected to grow by 11.79% on average over the next years. This is quite good.
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SOL Yearly Revenue VS EstimatesSOL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
SOL Yearly EPS VS EstimatesSOL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5 -2 -2.5

6

4. Valuation

4.1 Price/Earnings Ratio

  • SOL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • SOL is valuated reasonably with a Price/Forward Earnings ratio of 9.37.
  • 98.18% of the companies in the same industry are more expensive than SOL, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.96, SOL is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 9.37
SOL Price Earnings VS Forward Price EarningsSOL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

  • 70.91% of the companies in the same industry are cheaper than SOL, based on the Enterprise Value to EBITDA ratio.
  • 100.00% of the companies in the same industry are more expensive than SOL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.96
EV/EBITDA 304.9
SOL Per share dataSOL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • SOL's earnings are expected to grow with 72.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.8%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for SOL!.
Industry RankSector Rank
Dividend Yield 0%

EMEREN GROUP LTD

NYSE:SOL (12/12/2025, 8:04:00 PM)

After market: 1.94 0 (0%)

1.94

+0.01 (+0.52%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)11-12
Earnings (Next)03-11
Inst Owners43.09%
Inst Owner Change-86.37%
Ins Owners1.06%
Ins Owner Change0%
Market Cap99.56M
Revenue(TTM)71.23M
Net Income(TTM)-9.13M
Analysts80
Price Target7.14 (268.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-33.08%
Min Revenue beat(2)-34.82%
Max Revenue beat(2)-31.34%
Revenue beat(4)0
Avg Revenue beat(4)-30.41%
Min Revenue beat(4)-40.72%
Max Revenue beat(4)-14.76%
Revenue beat(8)2
Avg Revenue beat(8)-16.88%
Revenue beat(12)2
Avg Revenue beat(12)-26.69%
Revenue beat(16)3
Avg Revenue beat(16)-26.82%
PT rev (1m)0%
PT rev (3m)55.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.37
P/S 1.4
P/FCF 2.96
P/OCF 2.22
P/B 0.32
P/tB 0.32
EV/EBITDA 304.9
EPS(TTM)-0.21
EYN/A
EPS(NY)0.21
Fwd EY10.67%
FCF(TTM)0.66
FCFY33.81%
OCF(TTM)0.87
OCFY44.98%
SpS1.39
BVpS6.05
TBVpS6.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.03%
ROE -2.94%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.95%
FCFM 47.26%
ROA(3y)-1.47%
ROA(5y)-0.45%
ROE(3y)-2.16%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.71%
GM growth 5Y-1.82%
F-Score3
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 2.04
Debt/EBITDA 222.61
Cap/Depr 131.99%
Cap/Sales 15.62%
Interest Coverage N/A
Cash Conversion 16346%
Profit Quality N/A
Current Ratio 4.28
Quick Ratio 4.28
Altman-Z -0.51
F-Score3
WACC9.96%
ROIC/WACCN/A
Cap/Depr(3y)305.97%
Cap/Depr(5y)240.17%
Cap/Sales(3y)29.54%
Cap/Sales(5y)22.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.15%
EPS Next Y116.83%
EPS Next 2Y72.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.5%
Revenue growth 3Y4.93%
Revenue growth 5Y-5.02%
Sales Q2Q%21.63%
Revenue Next Year-14.03%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-598.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y181.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y208.42%
OCF growth 3YN/A
OCF growth 5YN/A

EMEREN GROUP LTD / SOL FAQ

What is the fundamental rating for SOL stock?

ChartMill assigns a fundamental rating of 4 / 10 to SOL.


What is the valuation status of EMEREN GROUP LTD (SOL) stock?

ChartMill assigns a valuation rating of 6 / 10 to EMEREN GROUP LTD (SOL). This can be considered as Fairly Valued.


What is the profitability of SOL stock?

EMEREN GROUP LTD (SOL) has a profitability rating of 1 / 10.


How financially healthy is EMEREN GROUP LTD?

The financial health rating of EMEREN GROUP LTD (SOL) is 6 / 10.